D. Fraser

发表

Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative

S. Friedman, J. Kastelein, E. Pieterman, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Polymorphisms in an interferon‐γ receptor‐1 gene marker and susceptibility to periodontitis*

U. van der Velden, B. Loos, Z. Dembić, 2003, Acta odontologica Scandinavica.

Interferon‐γ Receptor‐1 Gene Polymorphism in Tuberculosis Patients from Croatia

J. Pavelić, J. Dellacasagrande, Z. Dembić, 2003, Scandinavian journal of immunology.

Icosabutate Exerts Beneficial Effects Upon Insulin Sensitivity, Hepatic Inflammation, Lipotoxicity, and Fibrosis in Mice

E. Pieterman, C. Alonso, M. Iruarrizaga-Lejarreta, 2019, Hepatology communications.

Icosabutate, a Structurally Engineered Fatty Acid, Improves the Cardiovascular Risk Profile in Statin-Treated Patients with Residual Hypertriglyceridemia

J. Kastelein, D. Orloff, R. Vige, 2016, Cardiology.

A structurally engineered fatty acid, icosabutate, suppresses liver inflammation and fibrosis in NASH.

D. Schuppan, J. Kastelein, M. Iruarrizaga-Lejarreta, 2021, Journal of hepatology.

Structurally-engineered fatty acid 1024 (SEFA-1024) improves diet-induced obesity, insulin resistance, and fatty liver disease.

L. Anez-Bustillos, M. Puder, D. Dao, 2022, Lipids.

A Preliminary Study of Circadian Serum Cortisol Concentrations in Response to a 72-hour Fast in Rheumatoid Arthritis Patients not Previously Treated with Corticosteroids

J. Thoen, J. Kjeldsen-Kragh, O. Djøseland, 2001, Clinical Rheumatology.

Reduction in serum leptin and IGF-1 but preserved T-lymphocyte numbers and activation after a ketogenic diet in rheumatoid arthritis patients.

J. Thoen, J. Reseland, O. Førre, 2000, Clinical and experimental rheumatology.

Serum levels of interleukin-6 and dehydroepiandrosterone sulphate in response to either fasting or a ketogenic diet in rheumatoid arthritis patients.

J. Thoen, O. Førre, J. Kjeldsen-Kragh, 2000, Clinical and experimental rheumatology.

The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes

L. Diep, I. Seljeflot, K. Hanssen, 2012, Diabetes Care.

Changes in plasma free fatty acid concentrations in rheumatoid arthritis patients during fasting and their effects upon T-lymphocyte proliferation.

J. Thoen, O. Førre, J. Kjeldsen-Kragh, 1999, Rheumatology.

Icosabutate for the treatment of very high triglycerides: A placebo-controlled, randomized, double-blind, 12-week clinical trial.

J. Kastelein, D. Orloff, R. Vige, 2016, Journal of clinical lipidology.

Diet therapy for the patient with rheumatoid arthritis?

O. Førre, M. Haugen, D. Fraser, 1999, Rheumatology.

Triglycerides-diabetes association in healthy middle-aged men: modified by physical fitness? A long term follow-up of 1962 Norwegian men in the Oslo Ischemia Study.

K. Liestøl, S. Kjeldsen, J. Erikssen, 2013, Diabetes research and clinical practice.

Fasting Serum Triglycerides Predict New Onset Diabetes in Healthy Middle-Aged Men A 35-year follow-up of a Norwegian cohort Running title : Triglycerides Predict New Onset Diabetes

K. Liestøl, S. Kjeldsen, J. Erikssen, 2011 .

Decreased CD4+ Lymphocyte Activation and Increased Interleukin-4 Production in Peripheral Blood of Rheumatoid Arthritis Patients After Acute Starvation

J. Thoen, J. Reseland, J. Kjeldsen-Kragh, 1999, Clinical Rheumatology.

Icosabutate: targeting metabolic and inflammatory pathways for the treatment of NASH

D. Schuppan, S. Harrison, D. Fraser, 2022, Expert opinion on investigational drugs.

Abstract 18507: Icosabutate, a Novel Structurally Enhanced Fatty-acid Increases Hepatic Uptake of Cholesterol and Triglycerides in Conjunction With Increased Hepatic LDL Receptor Expression

E. Pieterman, H. Princen, C. Husberg, 2014 .